Indications and Purposes
| Indications And Usage Tice ® Bcg Is Indicated For: The Treatment And Prophylaxis Of Carcinoma In Situ (Cis) Of The Urinary Bladder The Prophylaxis Of Primary Or Recurrent Stage Ta And/or T1 Papillary Tumors Following Transurethral Resection (Tur) Limitations Of Use: Tice Bcg Is Not Recommended For Stage Tag1 Papillary Tumors, Unless They Are Judged To Be At High Risk Of Tumor Recurrence. Tice Bcg Is Not Indicated For Papillary Tumors Of Stages Higher Than T1. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Bacillus Calmette-Guerin Substrain Tice Live Antigen |